Galapagos, Gilead and innovative medicines
After the separation, Gilead will hold around 25% of the outstanding shares in both Galapagos and the spin-off company. While ...
The beleaguered Belgian firm Galapagos is splitting itself into two companies, with the brandname biotech prioritizing ...
This was the stock's fourth consecutive day of losses.
And other news from Christians around the world.
RBC Capital analyst Brian Abrahams lowered the firm’s price target on Gilead (GILD) to $83 from $84 and keeps a Sector Perform rating on the ...
TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy ...
Gilead stock rated buy for thriving HIV biz, promising oncology pipeline, and long-term growth potential despite volatility.
This was the stock's third consecutive day of losses.
Irish Independent on MSN1d
Gilead gives its blessing to Poolbeg Pharma’s Hookpia merger dealUS biopharmaceuticals giant Gilead has thrown its weight behind a potential merger of Ireland’s Poolbeg Pharma and Austria ...
The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...
The swimmers started out 2025 with a meet hosted by Marion Harding. This meet also included D1 Hilliard Darby, River Valley, Elgin and Wynford. With a reduced squad due to illness, the Indians came in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback